First patient in Malaysia successfully treated with Urolastic™ – collaboration between Leader Biomedical and Urogyn yields first results
26 September 2017- AMSTERDAM | MALAYSIA- Urogyn B.V. and Leader Biomedical announce the first patient treated in Malaysia with Urolastic™– an innovative Urinary Stress Incontinence product that is exclusively offered by Leader Biomedical in India and APAC.
We are excited to announce that we have successfully introduced Urolastic™ in Malaysia and treated a female patient suffering from severe Stress Urinary Incontinence (SUI). The patient suffered from the condition, as a result of birth deficiencies and was diagnosed with a short, yet very wide urethra. After previously undergoing a procedure using a bulking agent, the patient went down from using eight pads a day, to five pads a day. Treatment with Urolastic™ earlier this month by Dr. Warren Lo Hwa Loon at Pantai Hospital Kuala Lumpur has improved the patient’s condition, as a result of which she now only uses one pad a day, thus significantly improving her quality of life.
Stress Urinary Incontinence is a disease affecting over 200 million people worldwide. Traditionally, SUI is treated with either a sling or injection of a bulking agent, where a sling procedure is an invasive procedure for the patient and the traditional bulking agents are expensive, as they are only effective for a short period and need to be repeated regularly.
“Patients who would benefit from bulking agent procedure are those that suffered from a failed sling procedure, elderly patients that are happy with a positive effect and incontinence reduction rather than a guaranteed total stop of leakage, and patients that prefer minimally-invasive surgery as opposed to sling procedure surgery” shares Dr. Warren Lo Hwa Loon, Pantai Hospital Kuala Lumpur.
“Urolastic™ is the most effective bulking agent available to patients suffering from SUI. The agent stays at the application site since it is not a fluid in the body, but hardens to form a solid mass. Also, treatment with Urolastic™ is an outpatient procedure in most cases. In addition to being an attractive procedure for the elderly and after failed sling procedures, it also provides an alternative for women who still wish to have children”, adds Dr. Pieter Venema, urologist and experienced Urogyn trainer from the Netherlands.
READ MORE ON: www.leaderbiomedical.com